For BxPC-3 cells that were not KRAS mutants, we performed experiments on another two pancreatic cancer cell lines, MIAPaca-2 and Panc-1 with KRAS mutant22 and SMO-positive14, respectively (Fig. 2D,E). This evidence concerns the gene SMO and familial pancreatic carcinoma.